A Randomized, Double-Blind, Placebo-Controlled Trial of Metformin in Reducing Progression Among Men on Expectant Management for Low Risk Prostate Cancer: The MAST (Metformin Active Surveillance Trial) Study
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Metformin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms MAST
- 19 Apr 2021 Biomarkers information updated
- 01 Oct 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 15 Jun 2013 New trial record